MedPath
NMPA Approval

Ribostamycin Sulfate for Injection

国药准字H46020474

July 15, 2024

Drug Information

注射用硫酸核糖霉素

注射剂

0.5g(50万单位)

化学药品

July 15, 2024

Company Information

Applicant Company

海口市南海大道281号

Manufacturing Company

海口市药谷三横路6号

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

注射用硫酸核糖霉素 - NMPA 批准文号 | MedPath